Abstract

Complete reconstitution of the vancomycin-intermediate Staphylococcus aureus (VISA) phenotype of strain Mu50 was achieved by sequentially introducing mutations into six genes of vancomycin-susceptible S. aureus (VSSA) strain N315ΔIP. The six mutated genes were detected in VISA strain Mu50 but not in N315ΔIP. Introduction of the mutation Ser329Leu into vraS, encoding the sensor histidine kinase of the vraSR two-component regulatory (TCR) system, and another mutation, Glu146Lys, into msrR, belonging to the LytR-CpsA-Psr (LCP) family, increased the level of vancomycin resistance to that detected in heterogeneous vancomycin-intermediate S. aureus (hVISA) strain Mu3. Introduction of two more mutations, Asn197Ser into graR of the graSR TCR system and His481Tyr into rpoB, encoding the β subunit of RNA polymerase, converted the hVISA strain into a VISA strain with the same level of vancomycin resistance as Mu50. Surprisingly, however, the constructed quadruple mutant strain ΔIP4 did not have a thickened cell wall, a cardinal feature of the VISA phenotype. Subsequent study showed that cell wall thickening was an inducible phenotype in the mutant strain, whereas it was a constitutive one in Mu50. Finally, introduction of the Ala297Val mutation into fdh2, which encodes a putative formate dehydrogenase, or a 67-amino-acid sequence deletion into sle1 [sle1(Δ67aa)], encoding the hydrolase of N-acetylmuramyl-l-alanine amidase in the peptidoglycan, converted inducible cell wall thickening into constitutive cell wall thickening. sle1(Δ67aa) was found to cause a drastic decrease in autolysis activity. Thus, all six mutated genes required for acquisition of the VISA phenotype were directly or indirectly involved in the regulation of cell physiology. The VISA phenotype seemed to be achieved through multiple genetic events accompanying drastic changes in cell physiology.

Highlights

  • Complete reconstitution of the vancomycin-intermediate Staphylococcus aureus (VISA) phenotype of strain Mu50 was achieved by sequentially introducing mutations into six genes of vancomycin-susceptible S. aureus (VSSA) strain N315⌬IP

  • We previously reported that the tagO, cmk, or rpoB mutation was found in a VISA strain obtained from an heterogeneous vancomycin-intermediate S. aureus (hVISA) strain [6, 18]

  • We have already reported that strain ⌬IP1 has increased vancomycin resistance, and a typical population curve for the hVISA strain is shown in Fig. 1 [10]

Read more

Summary

Introduction

Complete reconstitution of the vancomycin-intermediate Staphylococcus aureus (VISA) phenotype of strain Mu50 was achieved by sequentially introducing mutations into six genes of vancomycin-susceptible S. aureus (VSSA) strain N315⌬IP. The mutations had the same effect, i.e., constitutive activation of vraSR and upregulation of the genes involved in cell wall synthesis [10] Such vraS mutations are frequently observed in hVISA strains in Japan [12] and may represent first-step mutations leading to the acquisition of the VISA phenotype [10, 13, 14]. We planned to reconstitute the entire VISA phenotype in a naive vancomycin-susceptible methicillin-resistant S. aureus (MRSA) strain which had not been exposed to vancomycin For this project, we chose laboratory strain N315⌬IP (⌬IP), a laboratory derivative of clinical pre-MRSA strain N315 in which mecI was inactivated and the plasmid carrying the gene for penicillinase (PCase; ␤-lactamase) was eliminated. This strain did not the express VISA phenotype

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call